The Need for Better Data on Patients with Acute Stroke Who Are Not Treated Because of Unfavorable Imaging

References

1. 1.↵
   2. Menon BK,
   3. Campbell BC,
   4. Levi C, et al

   . Role of imaging in current acute ischemic stroke workflow for endovascular therapy. Stroke 2015;46:1453–61 doi:10.1161/STROKEAHA.115.009160 pmid:25944319

   Abstract/FREE Full Text
2. 2.↵
   2. Olivot JM,
   3. Mlynash M,
   4. Thijs VN, et al

   . Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke 2009;40:1692–97 doi:10.1161/STROKEAHA.108.538082 pmid:19299632

   Abstract/FREE Full Text
3. 3.↵
   2. Menon BK,
   3. Sajobi TT,
   4. Zhang Y, et al

   . Analysis of workflow and time to treatment on thrombectomy outcome in the ESCAPE randomized controlled trial. Circulation 2016:CIRCULATIONAHA. 115.019983
4. 4.↵
   2. Saver JL,
   3. Goyal M,
   4. van der Lugt A, et al

   . Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016;316:1279–88 doi:10.1001/jama.2016.13647 pmid:27673305

   CrossRefPubMed
5. 5.↵
   2. Goyal M,
   3. Almekhlafi MA,
   4. Fan L, et al

   . Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial. Circulation 2014;130:265–72 doi:10.1161/CIRCULATIONAHA.113.007826 pmid:24815501

   Abstract/FREE Full Text
6. 6.↵
   2. Khatri P,
   3. Abruzzo T,
   4. Yeatts SD, et al

   . Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066–72 doi:10.1212/WNL.0b013e3181b9c847 pmid:19786699

   CrossRefPubMed
7. 7.↵
   2. Menon BK,
   3. Almekhlafi MA,
   4. Pereira VM, et al

   . Optimal workflow and process-based performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR thrombectomy for acute revascularization study. Stroke 2014;45:2024–29 doi:10.1161/STROKEAHA.114.005050 pmid:24876244

   Abstract/FREE Full Text
8. 8.↵
   2. Saver JL,
   3. Fonarow GC,
   4. Smith EE, et al

   . Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013;309:2480–88 doi:10.1001/jama.2013.6959 pmid:23780461

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Goyal M,
   3. Menon BK,
   4. van Zwam WH, et al

   . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31 doi:10.1016/S0140-6736(16)00163-X pmid:26898852

   CrossRefPubMed
10. 10.↵
    2. Zhang H,
    3. Prabhakar P,
    4. Sealock R, et al

    . Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke. J Cereb Blood Flow Metab 2010;30:923–34 doi:10.1038/jcbfm.2010.10 pmid:20125182

    Abstract/FREE Full Text
11. 11.↵
    2. Menon BK,
    3. Smith EE,
    4. Coutts SB, et al

    . Leptomeningeal collaterals are associated with modifiable metabolic risk factors. Ann Neurol 2013;74:241–48 doi:10.1002/ana.23906 pmid:23536377

    CrossRefPubMed
12. 12.↵
    2. Sargento-Freitas J,
    3. Pagola J,
    4. Rubiera M, et al

    . Preferential effect of premorbid statins on atherothrombotic strokes through collateral circulation enhancement. Eur Neurol 2012;68:171–76 doi:10.1159/000337862 pmid:22906913

    CrossRefPubMed
13. 13.↵
    2. Hill MD,
    3. Martin RH,
    4. Mikulis D, et al

    . Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2012;11:942–50 doi:10.1016/S1474-4422(12)70225-9 pmid:23051991

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Liu Z,
    3. Fan Y,
    4. Won SJ, et al

    . Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007;38:146–52 doi:10.1161/01.STR.0000251791.64910.cd pmid:17122429

    Abstract/FREE Full Text
15. 15.↵
    2. Waring W

    . Uric acid: an important antioxidant in acute ischaemic stroke. QJM 2002;95:691–93 doi:10.1093/qjmed/95.10.691 pmid:12324642

    FREE Full Text
16. 16.↵
    2. Serles W,
    3. Gattringer T,
    4. Mutzenbach S, et al

    . Endovascular stroke therapy in Austria: a nationwide 1-year experience. Eur J Neurol 2016;23:906–11 doi:10.1111/ene.12958 pmid:26843095

    CrossRefPubMed
17. 17.↵
    2. Hill MD,
    3. Goyal M,
    4. Demchuk AM, et al

    . Ischemic stroke tissue-window in the new era of endovascular treatment. Stroke 2015;46:2332–34 doi:10.1161/STROKEAHA.115.009688 pmid:26111893

    FREE Full Text